I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The synergistic antitumor activity of 3-(2-nitrophenyl) pro..:
Xiao-Chuan Duan
;
Li-Yuan Peng
;
Xin Yao
...
http://dx.doi.org/10.1080/10717544.2021.1909180. , 2021
Link:
https://doi.org/10.1080/10717544.2021.1909180
RT Journal T1
The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:833feb7b030d426a96d2efbd4c05e78f&Exemplar=1&LAN=DE A1 Xiao-Chuan Duan A1 Li-Yuan Peng A1 Xin Yao A1 Mei-Qi Xu A1 Hui Li A1 Shuai-Qiang Zhang A1 Zhuo-Yue Li A1 Jing-Ru Wang A1 Zhen-Han Feng A1 Guang-Xue Wang A1 Ai Liao A1 Ying Chen A1 Xuan Zhang PB Taylor & Francis Group YR 2021 K1 3-(2-nitrophenyl) propionic acid-paclitaxel K1 nanoparticles K1 immunogenic cell death K1 anti-pd-l1 antibody K1 immune response K1 synergistic antitumor activity K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/10717544.2021.1909180 LK http://dx.doi.org/https://doi.org/10.1080/10717544.2021.1909180 DO https://doi.org/10.1080/10717544.2021.1909180 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)